Correspondence
Keith D. Lindor, MD, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
Tel: +1 507 284 2969
Fax: +1 507 266 4531
e-mail: [email protected]

Read the full text

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

Abstract

Background/Aims: Primary biliary cirrhosis (PBC) is frequently associated with autoimmune diseases, including thyroid disease, although it is uncertain that this association is higher than in other liver diseases.

Methods: We compared the prevalence and incidence of thyroid dysfunction (TD) in a series of patients with PBC (n=67) with patients with primary sclerosing cholangitis (PSC) (n=79) and non-alcoholic fatty liver disease (NAFLD) (n=97) seen in a tertiary referral centre who had previously participated in clinical trials.

Results: At initial evaluation, prevalence of TD in PBC was 13% compared with 11% in PSC (P=0.71) and 25% in NAFLD (P=0.08). Incidence of TD was 2.9 patients per 100 person-years in PBC compared with 2.1 patients per 100 person-years in PSC (P=0.57) and 1.8 patients per 100 person-years in non-alcoholic liver disease (P=0.45). Older age, female gender, biochemical abnormalities and concurrent autoimmune disorders were not predictive of the development of TD.

Conclusions: TD was unexpectedly as common in patients with PBC as in patients with PSC and NAFLD, yet significantly more common than expected in the general population. Further investigation of thyroid disease in PSC and NAFLD is warranted.

References

1 Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003; 362: 53–61.
10.1016/S0140-6736(03)13808-1
CAS PubMed Web of Science® Google Scholar
2 Angulo P, Lindor KD. Primary biliary cirrhosis and primary sclerosing cholangitis. Clin Liver Dis 1999; 3: 529–70.
10.1016/S1089-3261(05)70084-2
CAS PubMed Google Scholar
3 Tsianos EV, Hoofnagle JH, Fox PC, et al. Sjogren's syndrome in patients with primary biliary cirrhosis. Hepatology 1990; 11: 730–4.
10.1002/hep.1840110504
CAS PubMed Web of Science® Google Scholar
4 Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982; 57: 365–70.
CAS PubMed Web of Science® Google Scholar
5 Nieri S, Riccardo GG, Salvadori G, Surrenti C. Primary biliary cirrhosis and Graves' disease. J Clin Gastroenterol 1985; 7: 434–7.
10.1097/00004836-198510000-00014
CAS PubMed Web of Science® Google Scholar
6 Elta GH, Sepersky RA, Goldberg MJ, et al. Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci 1983; 28: 971–5.
10.1007/BF01311724
PubMed Web of Science® Google Scholar
7 Crowe JP, Christensen E, Butler J, et al. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and Sicca syndrome. Gastroenterology 1980; 78: 1437–41.
PubMed Web of Science® Google Scholar
8 Schussler GC, Schaffner F, Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease. N Engl J Med 1978; 299: 510–5.
10.1056/NEJM197809072991003
PubMed Web of Science® Google Scholar
9 Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973; 289: 674–8.
10.1056/NEJM197309272891306
CAS PubMed Web of Science® Google Scholar
10 Saarinen S, Olerup O, Broome U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 3195–9.
10.1111/j.1572-0241.2000.03292.x
CAS PubMed Web of Science® Google Scholar
11 Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid 2002; 12: 977–88.
10.1089/105072502320908312
PubMed Web of Science® Google Scholar
12 Menon KV, Kamath PS. Managing the complications of cirrhosis. Mayo Clin Proc 2000; 75: 501–9.
10.4065/75.5.501
CAS PubMed Web of Science® Google Scholar
13 Benelhadj S, Marcellin P, Castelnau C, et al. Incidence of dysthyroidism during interferon therapy in chronic hepatitis C. Horm Res 1997; 48: 209–14.
10.1159/000185517
CAS PubMed Web of Science® Google Scholar
14 Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284–90.
10.1016/0016-5085(94)90021-3
CAS PubMed Web of Science® Google Scholar
15 Lindor KD. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis–Ursodeoxycholic Acid Study Group. N Engl J Med 1997; 336: 691–5.
10.1056/NEJM199703063361003
PubMed Web of Science® Google Scholar
16 Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996; 23: 1464–7.
CAS PubMed Web of Science® Google Scholar
17 Lindor KD, Kowdley KV, Heathcote EJ, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 2004; 39: 770–8.
CAS PubMed Web of Science® Google Scholar
18 Abdelmalek MF, Angulo P, Jorgensen RA, Sylvestre PB, Lindor KD. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 2001; 96: 2711–7.
CAS PubMed Web of Science® Google Scholar
19 Murtaugh PA, Dickson ER, Van Dam GM, et al. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 1994; 20 (Part 1): 126–34.
CAS PubMed Web of Science® Google Scholar
20 Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489–99.
CAS PubMed Web of Science® Google Scholar
21 Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977; 7: 481–93.
PubMed Web of Science® Google Scholar
22 Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43: 55–68.
PubMed Web of Science® Google Scholar
23 Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228–38.
CAS PubMed Web of Science® Google Scholar
24 Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526–34.
10.1001/archinte.160.4.526
CAS PubMed Web of Science® Google Scholar
25 Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 2001; 33: 16–21.
10.1053/jhep.2001.21165
CAS PubMed Web of Science® Google Scholar
26 Montefusco PP, Geiss AC, Bronzo RL, et al. Sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: a syndrome complex. Am J Surg 1984; 147: 822–6.
PubMed Web of Science® Google Scholar
27 Bjornsson E, Chari ST, Smyrk TC, Lindor K. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007; 45: 1547–54.
Web of Science® Google Scholar
28 Liangpunsakul S, Chalasani N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? J Clin Gastroenterol 2003; 37: 340–3.
10.1097/00004836-200310000-00014
PubMed Web of Science® Google Scholar
29 Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25: 883–9.
CAS PubMed Web of Science® Google Scholar
30 Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007; 92: 491–6.
10.1210/jc.2006-1718
CAS PubMed Web of Science® Google Scholar
31 Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006; 91: 4930–7.
10.1210/jc.2006-0478
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume29, Issue7

August 2009

Pages 1094-1100

Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease

Abstract

References

Citing Literature

References

Related

Information